Dr. Kandasamy has over 10 years of experience in oligonucleotide research and development. He worked on siRNA delivery technologies for 5 years at Alnylam prior to joining the Medicinal Chemistry group at Wave in 2016. He earned a Ph.D. in synthetic carbohydrate chemistry focused on discovering new methods for stereospecific anomeric C-O and C-C bond formation related to GalNAc sugars from the Indian Institute of Technology Kanpur (India) before completing postdoctoral work on glycopeptides at the University of Konstanz (Germany) with Professor Richard R. Schmidt and worked on aminoglycosides antibiotics at University of Montreal (Canada) with Professor Stephan Hanessian.